PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats

Go back to PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats
PACIFIC BIO CA (NASDAQ: PACB) Delayed: 5.73 +0.22 (3.99%)
Previous Close $5.51    52 Week High $14.00 
Open $5.68    52 Week Low $6.61 
Day High $5.94    P/E N/A 
Day Low $5.46    EPS $-1.26 
Volume 4,479,697